Get started
Author

Rama Vancheeswaran

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
2022 · Wanwisa Dejnirattisai, Jiandong Huo, et al. · Cell · 949
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566
PDF
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial
2022 · Gavin D. Perkins, Chen Ji, et al. · JAMA · 417
PDF
Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
2013 · Chloe I. Bloom, Christine M. Graham, et al. · PLoS ONE · 315
PDF
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
1994 · R Vancheeswaran, T Magoulas, et al. · PubMed · 238
Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.
1997 · D J Abraham, R Vancheeswaran, et al. · Europe PMC (PubMed Central) · 210
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
2021 · Thomas M Drake, Aya M Riad, et al. · The Lancet · 162
PDF
Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1
1994 · H. Higley, K. Persichitte, et al. · Arthritis & Rheumatism · 158
Localization of endothelin-1 and its binding sites in scleroderma skin.
1994 · R Vancheeswaran, A Azam, et al. · PubMed · 126
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
2024 · Felicity Liew, Claudia Efstathiou, et al. · Nature Immunology · 124
PDF
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 120
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions
2020 · Felix Chua, Darius Armstrong-James, et al. · The Lancet Respiratory Medicine · 102
PDF
Childhood‐onset scleroderma: Is it different from adult‐onset disease?
1996 · Rama Vancheeswaran, Carol M. Black, et al. · Arthritis & Rheumatism · 102
Hla type as a predictor of mixed connective tissue disease differentiation ten‐year clinical and immunogenetic followup of 46 patients
1995 · Nagui S. T. Gendi, Ken I. Welsh, et al. · Arthritis & Rheumatism · 102
Increased susceptibility to oxidation of low‐density lipoproteins isolated from patients with systemic sclerosis
1995 · K. Richard Bruckdorfer, Janet B. Hillary, et al. · Arthritis & Rheumatism · 96
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
2021 · Thushan I. de Silva, Guihai Liu, et al. · iScience · 93
PDF
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
2019 · Joseph Barnett, Philip L. Molyneaux, et al. · European Respiratory Journal · 91
PDF
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
2021 · Gavin D Perkins, Chen Ji, et al. · medRxiv · 55
PDF
Correction: Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
2013 · Chloe I. Bloom, Christine M. Graham, et al. · PLoS ONE · 55
PDF
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
2023 · Benedict D. Michael, Cordelia Dunai, et al. · Nature Communications · 52
PDF
Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function–associated antigen 3 by normal and scleroderma fibroblasts.
1994 · Xu Shi‐Wen, Manvinder Panesar, et al. · Arthritis & Rheumatism · 46
ALPHA INTERFERON-2a (ROFERON-A) IN THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A PILOT STUDY
1992 · W. STEVENS, R. VANCHEESWARAN, et al. · Rheumatology · 41
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
2023 · Hannah Goldswain, Xiaofeng Dong, et al. · Genome biology · 39
PDF
International Pediatric COVID-19 Severity Over the Course of the Pandemic
2023 · Yanshan Zhu, Flávia Jacqueline Almeida, et al. · Archives of Pediatrics and Adolescent Medicine · 38
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
2022 · Fiina Närhi, S Ramani Moonesinghe, et al. · The Lancet Digital Health · 36
PDF
Works count: 79
Citation count: 4,997
H-index: 29
I10-index: 35
Year
Topic
Type